Commodities

European drug wholesaler Abacus secures investor to fund growth

Danish drug merchant Abacus Medicine will sell 48 million euros ($53 million) worth of new shares to investment firm Chr. Augustinus Fabrikker after it called off a planned share listing in May. [nL4N2354N0]

Sept 2 (Reuters) - Danish drug merchant Abacus Medicine will sell 48 million euros ($53 million) worth of new shares to investment firm Chr. Augustinus Fabrikker after it called off a planned share listing in May.

Abacus buys medicines in cheaper parts of the European Union to sell them in more expensive markets such as Germany.

Fabrikker will acquire a stake of slightly more than a third of Abacus as part of a capital increase to fund drug purchases, product licences and expansion in new regional markets, among other growth projects, Abacus said in a statement on Monday.

"Abacus contributes positively to making pharmaceuticals more affordable for patients in most EU countries," Fabrikker's Chief Executive Claus Gregersen said, adding the firm would be a long-term co-owner.

Founder and Chief Executive Flemming Wagner will retain a majority stake, the statement said.

Though there are no current IPO plans, such a move remains an interesting option over the long term, Wagner was quoted as saying in Danish daily Borsen.

Abacus' main business is the so-called parallel trade of medicines in Europe, buying batches from wholesalers in low-price countries and making cross-border sales to other distributors.

($1 = 0.8973 euros)

(Additional reporting by Nikolaj Skydsgaard in Copenhagen; Editing by Mark Potter)

((ludwig.burger@thomsonreuters.com; +49 69 7565 1311; Reuters Messaging: ludwig.burger.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Commodities Videos

#TradeTalks: Underlying Deflationary Pressures – Commodity Review

Jill Malandrino is joined by Peter Borish, Chief Strategist at Quad Group, to discuss deflationary pressures as well as the commodity review.

Feb 7, 2020

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More